Is MMTX.SW up or down today?
MMTX.SW is down 0.72% today, last at 229.93. This stock moved -0.72% versus the prior close.
MMTX.SW · MMTX.SW
MMTX.SW (MMTX.SW) is trading at 229.93, down 0.72% on the session. Price action shows weakness or stretched conditions worth watching.
Headline tone is mostly neutral. Recent headlines haven't moved the price much yet.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
MMTX.SW is down 0.72% today, last at 229.93. This stock moved -0.72% versus the prior close.
Headline tone is mostly neutral. Recent headlines haven't moved the price much yet. Dominant story: MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy (1 source, bullish) RSI is 54 — neutral Price below 50-day average — short-term weakness Social (demo): 38% of recent mentions lean bullish — social mood is cautious.
Loaded: Jan 2026 – Jul 2026 (181 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 12,518 mentions over 30d
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
MindMaze Therapeutics Announces Results of Annual General Meeting
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification